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Abstract
Objective To determine women's preferences for and reported experience with medical test decision-making.
Design Computer-assisted telephone survey. Setting and participants Six hundred and fifty-two women
resident in households randomly selected from the New South Wales electronic white pages. Main outcome
measures Reported and preferred test and treatment (for comparison) decision-making, satisfaction with and
anxiety about information on false results and side-effects; and effect of anxiety on desire for such
information. Results Overall most women preferred to share test (94.6%) and treatment (91.2%) decision-
making equally with their doctor, or to take a more active role, with only 5.4-8.9% reporting they wanted the
doctor to make these decisions on their behalf. This pattern was consistent across all age groups. In general,
women reported experiencing a decision-making role that was consistent with their preference. Women who
had a usual doctor were more likely to report experiencing an active role in decision-making. More women
reported receiving as much information as they wanted about the benefits of tests and treatment than about
the side-effects of tests and treatment. Most women wanted information about the possibility of false test
results (91.5%) and test side-effects (95.6%), but many reported the doctor never provided this information
(false results = 40.0% and side-effects = 31.3%). A substantial proportion said this information would make
them anxious (false results = 56.6% and side-effects = 43.1%), but reported they wanted the information
anyway (false results = 77.6% and side-effects = 88.1%). Conclusions Women prefer an active role in test and
treatment decision-making. Many women reported receiving inadequate information. If so, this may
jeopardize informed decision-making.
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shared decision-making, medical tests
Abstract
Objective To determine women’s preferences for and reported
experience with medical test decision-making.
Design Computer-assisted telephone survey.
Setting and participants Six hundred and fifty-two women resident
in households randomly selected from the New South Wales
electronic white pages.
Main outcome measures Reported and preferred test and treatment
(for comparison) decision-making, satisfaction with and anxiety
about information on false results and side-effects; and effect of
anxiety on desire for such information.
Results Overall most women preferred to share test (94.6%) and
treatment (91.2%) decision-making equally with their doctor, or to
take a more active role, with only 5.4–8.9% reporting they wanted the
doctor to make these decisions on their behalf. This pattern was
consistent across all age groups. In general, women reported
experiencing a decision-making role that was consistent with their
preference.Womenwho had a usual doctor weremore likely to report
experiencing an active role in decision-making.Morewomen reported
receiving as much information as they wanted about the benefits of
tests and treatment than about the side-effects of tests and treatment.
Most women wanted information about the possibility of false test
results (91.5%) and test side-effects (95.6%), but many reported the
doctor never provided this information (false results ¼ 40.0% and
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side-effects ¼ 31.3%). A substantial proportion said this information
would make them anxious (false results ¼ 56.6% and side-
effects ¼ 43.1%), but reported they wanted the information anyway
(false results ¼ 77.6% and side-effects ¼ 88.1%).
Conclusions Women prefer an active role in test and treatment
decision-making. Many women reported receiving inadequate
information. If so, this may jeopardize informed decision-making.
Introduction
Decision-making shared by patients and doctors
is advocated to involve patients in decisions
about their care.1–6 However, advocating such a
role for patients ignores variation in patients
preferences for involvement in decision-making.
While some patients want to make decisions
themselves, others prefer to delegate decision-
making to their doctor or share decision-making
with their doctor. Previous studies have reported
wide variation in preferences for involvement in
decision-making about treatment.7–15 Many of
the studies looking at treatment decision-making
have been conducted with patients already in the
health-care system7–15 who are more likely to
select a passive decision-making role than
healthy people.11 The few studies that have used
a community-based sample16 or included non-
patient samples for comparison,11,14,15 have fo-
cused on decision-making preferences regarding
treatment, to the exclusion of preferences for test
decision-making. There are no data about pref-
erences in relation to test decision-making and the
extent to which these preferences would mirror
results for treatment is unclear. Community
sampling is necessary for eliciting information
about test decision-making, as decisions about
whether to undergo a screening and/or diagnostic
test are usually the entry point to the health sys-
temmade by people living in the community. The
General Medical Council in the United King-
dom17 recently provided guidance to health care
providers about information that should be given
to people considering screening tests. To our
knowledge, no similar guidance is available about
information that should be given to people
undergoing diagnostic tests.
It is currently unknown whether people want
to participate in decisions about whether to
undergo screening and diagnostic tests, whether
they feel they are currently participating in these
decisions, what information they are currently
receiving and what information they would like
to receive. Therefore, the aims of this study were
to: (1) elicit women’s preferences for test and
treatment (for comparison) decision-making;
(2) compare these to their reported experiences
of medical test, breast test and treatment decis-
ion-making; and (3) assess women’s preferences
for information concerning false test results and




The sample consisted of women aged
30–69 years inclusive, who were resident in New
South Wales (NSW) at the time the study was
conducted, had access to a telephone listed in the
electronic white pages and spoke English well
enough to participate in a telephone interview.
This age group is consistent with a previous
survey on breast health18–20 and includes both
the age range with high rates of breast symptoms
and breast tests21 and the age range targeted by
the national mammographic screening pro-
gramme.22 Although this programme is specif-
ically aimed at women aged 50–69 years, it offers
free mammograms to all women aged 40 years
and over who have no symptoms of breast
cancer. Therefore, the sample is likely to include
many women who have had personal experience
with breast tests.
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Procedure
The Hunter Valley Research Foundation
administered the survey using a Computer-
Assisted Telephone Interviewing (CATI) system.
Households randomly selected from the NSW
electronic white pages were sent a letter intro-
ducing the study 1 week before the first tele-
phone contact. Up to 10 attempts were made to
contact the household. Once a household was
contacted, the interviewer asked if a person fit-
ting the eligibility criteria (an English-speaking
woman aged 30–69 years inclusive) lived in the
house. Where more than one person fitted the
criteria, the number of people fitting the criteria
was obtained and the CATI program selected
one person at random (e.g. oldest, third oldest).
Once a person was selected, no substitution was
permitted. If she was unavailable, up to five
further call attempts were made. The survey
took approximately 20 min. Quotas were used
to ensure at least 150 women were interviewed
within each decade of age (30–39, 40–49, 50–59,
60–69) as responses from women from all age
categories were of equal interest and we wanted
good precision (95% confidence intervals of
±8%) for estimates in the older age groups.
The Human Ethics Committee of The Uni-
versity of Sydney approved the study.
Survey development
The survey consisted of six sections designed to
elicit information on women’s sociodemo-
graphic details, preferences for test and treat-
ment decision-making, reported test, breast test
and treatment decision-making, and informa-
tion needs related to medical tests. The majority
of the survey consisted of questions developed
by the researchers. Published questions were
available for the sections on preferred decision-
making role. Questions in this section of the
survey were adapted from The Control Prefer-
ences Scale,23 which uses five cards in a series of
two-card comparisons to elicit information on
respondents desired role in decision-making.
Initially developed using analysis of the way
treatment decisions are made by patients, it has
been used to measure preferences in patient and
non-patient populations.23 A final draft of the
survey was pilot tested to establish reliability
and facilitate the revision of problematic ques-
tions. To establish test–retest reliability, 106
women completed the survey once and then
again 1 week later. Questions and response
options were presented in the same order for
both administrations.
Reliability was assessed by the percentage of
responses with exact agreement on both occa-
sions and using j (for categorical variables) and
weighted j (for ordinal variables) statistics.
Comparison of answers given on both occasions
showed agreement of 80% or higher for 44% of
the questions, 60–79% for 41% of the questions
and 50–59% for the remaining 15% of ques-
tions. Using Landis and Koch’s classification,24
15% of questions had j or weighted j in the
almost perfect range (0.81–1.00), 18% of ques-
tions were in the substantial range (0.61–0.80),
41% were in the moderate range (0.41–0.60),
21% the fair range (0.21–0.40) and 6% had j
below 0.20. A review of the questions showed
that j and weighted j were high on questions
that would be expected to stay the same, such as
demographic items and items asking about pre-
vious tests (for example, Have you ever had a
mammogram?, j ¼ 0.981). Reliability for these
items was comparable with a previous Austra-
lian survey of women in the same age range.20
Items with lower j were judgment or preference
questions (such as were you given enough infor-
mation about the potential benefits of the test?),
which previous research shows change over
time.25 Minor changes were made to the wording
of some questions to facilitate respondent
understanding. The survey was then pilot tested
with a further sample of 30 women to assess the
acceptability of the changes. The final version of
the survey consisted of six sections. A copy of the
survey is available on request.
Sociodemographic details
Information was obtained on participants age,
suburb or town of residence, postcode, country
of birth, highest level of education completed
and employment status.
 Blackwell Science Ltd 2002 Health Expectations, 5, pp.330–340
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Preferred test and treatment decision-making
This section was designed to elicit decision-
making role preferences. Participants were asked
to imagine a hypothetical situation in which they
were considering whether or not to undergo a
cholesterol test. To elicit a test decision-making
preference from among the five options, each
participant was taken through a series of ques-
tions comparing two options at a time, using the
same approach as the card sort method devel-
oped by Degner and colleagues.23 In summary,
the options provided were: (a) she makes deci-
sions alone; (b) she makes decisions after seri-
ously considering the doctor’s opinion; (c) she
shares decision-making equally with the doctor;
(d) the doctor makes decisions after seriously
considering her opinion; and (e) the doctor
makes decisions alone. The full wording of each
option is available in the questionnaire. The
same method was used to elicit the participant’s
preferred treatment decision-making role. Par-
ticipants were asked to imagine they were
making a decision such as whether to take the
oral contraceptive pill or hormone replacement
therapy.
Reported test and treatment decision-making
Participants were asked a series of questions
about communication and decision-making with
their current or last doctor. Questions elicited
information on: whether women had a usual
doctor and if so, what type of doctor this was;
what role women played in making test
decisions; and if they received enough informa-
tion about test benefits and side-effects. In
regards to reported test decision-making,
participants were given two examples of a test
(blood test for cholesterol and X-rays for sus-
pected broken bones), asked to name a test they
had undergone (screening or diagnostic) and to
choose their decision-making role for that test
from one of three options, which were: (a) she
made the decision alone; (b) she shared decision-
making equally with the doctor; and (c) the
doctor made the decision alone. Analogous
questions were used to elicit information on
the participant’s reported treatment decision-
making role.
Reported decision-making role for breast tests
Participants were informed that tests for breast
disease included mammography and breast
biopsy. For mammograms, specific questions
pertained to: whether women had ever had a
mammogram; purpose of the mammogram
(screening or diagnostic); time since last
mammogram; information about potential
benefits and side-effects; and decision-making
involvement. For biopsy, questions elicited
information on: whether women had ever
undergone a breast biopsy; time since last
biopsy; and information received about benefits
and side-effects.
Information on test accuracy
Participants were informed that few tests are
100% accurate and that sometimes tests are
normal in people who really have a disease and
abnormal in healthy people. Participants were
also informed that tests can have side-effects and
were given the example of breast biopsy, which
can have side effects of pain, bleeding and/or
infection. This was followed by questions elicit-
ing information on: (a) the perceived frequency
of receiving information about false results and
side-effects; (b) desire for this information; (c)
perceived anxiety that this information might
create; and (d) views on whether this anxiety
would deter them from wanting the information.
Statistical analysis
Analyses were performed using SPSS v. 10.0 for
Windows.26 Significance testing was done using
v2 tests for nominal variables and v2 tests for
trend for ordinal variables, with P values of less
than 0.05 considered statistically significant. All
analyses were done separately for women who
reported a usual doctor and those who did not.
Results are reported for women with a usual
doctor only, unless there was a significant dif-
ference between women with a usual doctor and
women without one. In these instances, results
for women without a usual doctor are reported
separately in the text. Demographic character-
istics were examined from the Australian Bureau
of Statistics (ABS) census data27 and data on age
 Blackwell Science Ltd 2002 Health Expectations, 5, pp.330–340
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breakdown, area of residence, education, occu-
pation and country of birth (Australia vs. over-
seas) were tabulated according to ABS
categories. As we deliberately over sampled
older women, all results are presented as age-
specific rates, or weighted for age where the
weights were derived from the age distribution
of NSW women in the census data.
Results
Characteristics of the sample population
Of the 743 eligible women contacted, 652 com-
pleted the survey, representing an unadjusted
response rate of 87.8%. When adjusted for the
estimated number of eligible women (based on
census data) among the households that could
not be contacted (n ¼ 228) the response rate was
74.1%. Women aged 30–39 years were under-
represented and those aged 60–69 years were
over-represented compared to the population of
women in NSW (see Table 1). There were no
significant differences between the age-adjusted
survey population and the general population of
women in NSW as derived from Australian
Census data27 for region, education, occupation
and country of birth. Of the women surveyed,
91.1% reported having a usual doctor, 98.9% of
these being a family doctor.
Preferred test and treatment decision-making
Table 2 shows women’s decision-making pref-
erences for tests and treatment. Most women
preferred to share decision-making with
their doctor. For tests and treatment, women
younger than 60 (v2 ¼ 18.009, 1 df, P < 0.001;
v2 ¼ 9.984, 1 df, P ¼ 0.002, respectively), those
withmoreeducation(v2 ¼ 4.532,1 df,P ¼ 0.033;
v2 ¼ 22.108, 1 df, P < 0.001, respectively) and
women who reported they currently share
decision-making with their doctor (v2 ¼ 29.003,
8 df, P < 0.001; v2 ¼ 64.861, 8df, P < 0.001,
respectively) preferred to make the decision











30–39 23.5 – 33.0
40–49 27.6 – 29.8
50–59 25.6 – 20.6
60–69 23.3 – 16.6
Region
Metropolitan 64.6 65.0 65.6
Rural 35.4 35.0 34.4
Education
School only 62.0 59.9 58.5
Post-school 38.0 40.1 41.5
Occupation
Full-time paid 29.0 31.2 28.6
Part-time paid 28.2 29.5 24.9
Unemployed 1.1 1.1 3.6
Student 1.1 1.2 2.1
Other 40.5 37.1 40.9
Country of birth
Australia 77.6 77.7 68.9
Other 23.4 22.3 31.1
*According to Australian Bureau of Statistics census data.27
Includes home duties and retired.
Table 1 Comparison of demographic
characteristics of the study population,
age-adjusted study population and the
general population of women aged
30–69 years in NSW
 Blackwell Science Ltd 2002 Health Expectations, 5, pp.330–340
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doctor’s opinion (active role). In addition,
women who were in paid employment were
more likely to prefer an active role in decisions
about tests (v2 ¼ 42.000, 24 df, P ¼ 0.013).
Women residing in rural areas (v2 ¼ 14.240,
4 df, P ¼ 0.007) were more likely to prefer an
active treatment decision-making role. Country
of birth was not significantly related to preferred
test or treatment role.
Reported test and treatment decision-making
experience
A total of 628 women were able to recall
undergoing a test and to name or describe that
test. Table 3 shows the reported test decision-
making role by test category for those women
who could recall a test and who had a usual
doctor (n ¼ 546). For comparison, women’s
Table 2 Preferred decision-making role for tests and treatment (by age)
Age group (%)
30–39 40–49 50–59 60–69
Preferred test decision-making role
n ¼ 204 n ¼ 193 n ¼ 147 n ¼ 105
Woman decides 12.3 13.0 16.3 3.8
Woman decides after considering doctor’s opinion 28.4 32.8 27.2 14.3
Decide together 52.0 55.4 50.3 63.8
Doctor decides after considering woman’s opinion 5.0 4.7 3.4 6.7
Doctor decides 2.0 3.1 2.7 11.4
Preferred treatment decision-making role
n ¼ 202 n ¼ 194 n ¼ 147 n ¼ 104
Woman decides 4.5 5.7 9.5 3.8
Woman decides after considering doctor’s opinion 37.1 36.8 30.6 23.1
Decide together 55.0 52.8 56.5 59.6
Doctor decides after considering woman’s opinion 3.5 1.6 2.0 6.7
Doctor decides 0.0 3.1 1.4 6.7

















Woman decided 11.5 10.8 7.7 11.0 48.3 5.4
Decided together 40.7 34.9 50.0 40.8 34.5 75.4
Doctor decided 47.8 54.2 42.3 48.2 17.2 19.1
Information on benefits*
Wanted more 18.5 18.0 15.6 17.6 16.6 23.4
As much as wanted 79.4 80.7 82.4 79.8 66.7 73.5
More than wanted 2.1 1.2 2.0 2.6 16.7 3.0
Information on side-effects
Wanted more 46.5 54.2 46.1 47.6 48.2 34.3
As much as wanted 52.7 45.8 51.9 51.4 51.7 63.3
More than wanted 0.8 – 1.9 1.0 51.7 1.8
*Significant difference between blood test, X-ray, scan and pap smear comparisons (P < 0.05).
 Blackwell Science Ltd 2002 Health Expectations, 5, pp.330–340
Medical tests: women’s preferences and experience, H M Davey et al. 335
reported treatment decision-making role is also
shown, although details of the specific treatment
women had in mind when answering this ques-
tion were not collected.
There was a significant difference in decis-
ion-making role (v2 ¼ 38.678, 6 df, P < 0.001)
reported by women in the different test cat-
egories. However, the difference appears to
relate to women who nominated pap smears.
With the exception of these women, the pat-
tern for reported decision-making role and
information about benefits and side-effects is
fairly consistent between tests, but differs from
that for treatment. Reported decision-making
role for tests was not associated with any of
the demographic variables. Women with more
education (v2 ¼ 4.569, 1 df, P < 0.033) and
those born overseas reported wanting more
information about test benefits (v2 ¼ 10.674,
3 df, P ¼ 0.014). There was no relationship
between satisfaction with information on
benefits and age, region or occupation. People
in other occupations, including home duties
and retired reported wanting less informa-
tion about side-effects (v2 ¼ 30.842, 12 df,
P < 0.002). None of the other demographic
variables were associated with satisfaction with
information about side-effects.
For treatment decisions, women with less
education were more likely to report the doctor
made the decision alone (v2 ¼ 10.150, 1 df, P ¼
0.001). Reported treatment decision-making role
was not significantly related to age, region,
occupation or country of birth.
Satisfaction with information about benefits
and side-effects was not related to any of the
demographic variables.
Women without a usual doctor
A total of 54 women reported not having a
usual doctor. These women were more likely
than those with a usual doctor to report the
doctor made the test decision (v2 ¼ 8.863, 2 df,
P ¼ 0.012). For tests, 3.8% women said they
made the decision alone, 67.3% the doctor made
the decision and 28.8% shared decision-making
with the doctor. There was no difference by age,
region, education, occupation or country of
birth. For treatment decisions, information was
collected separately for women without a usual
doctor. These women were asked to think about
their last doctor. A total of 36.2% women said
they made the decision, 35.4% the doctor made
the decision and 28.4% shared decision-making
with the doctor. There was no association with
any demographic variable.
Reported breast test decision-making experience
A total of 60.6% of women reported having
ever undergone a mammogram. Significantly,
more women with a usual doctor (62.4%) than
without (42.1%) reported having had a
mammogram (v2 ¼ 8.930, 1 df, P ¼ 0.003).
Women aged 50 years and over were more
likely to have had a mammogram (v2 ¼
216.932, 1 df, P < 0.001), but less likely to have
had a diagnostic mammogram (v2 ¼ 46.296,
1 df, P < 0.001). Women who reported having
had a diagnostic mammogram were asked to
focus on that, all others to focus on their most
recent screening mammogram. Women aged
50 years and older and those who had under-
gone diagnostic mammography were more
likely to report the doctor made the decision
(v2 ¼ 5.279, 1 df, P ¼ 0.022, v2 ¼ 85.786, 2 df,
P < 0.001, respectively). Overall, more women
reported being satisfied with the information
they received about benefits than the informa-
tion they received about side-effects (Table 4).
Reported decision-making role and satisfaction
with benefits and side-effects was not related to
any demographic variable.
Women without a usual doctor
Women aged 50 years and older (v2 ¼ 17.451,
1 df, P < 0.001) and those living in non-met-
ropolitan areas were more likely to have had a
mammogram (v2 ¼ 6.814, 1 df, P ¼ 0.009).
There was no difference by education, occupa-
tion or country of birth. Fewer women without a
usual doctor were satisfied with the information
they received. A total of 62.5% of women
without a usual doctor were satisfied with the
information they received on benefits, while
37.5% wanted more information. 54.2% wanted
 Blackwell Science Ltd 2002 Health Expectations, 5, pp.330–340
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more information about side-effects, 41.7% were
satisfied with the information they received and
4.2% wanted less information.
Breast biopsy
A total of 11.5% of women reported having
ever had a breast biopsy. More women aged
50 years or older reported having had a breast
biopsy (v2 ¼ 184.348, 1 df, P < 0.001). There
was no difference by region, education, occu-
pation or country of birth. More women
reported being satisfied with the information
they received on benefits (67.2%) than on
side-effects (42.5%). More information about
benefits was wanted by 30.8% of women and
57.5% wanted more information about side-
effects. There were no differences by any
demographic variable.
Information on test accuracy
False results
Women most commonly reported their doctor
never explained the possibility of a false test
result (see Table 5). Although most women
wanted information about false results the next
time they had a medical test, women less than
60, and students and women in paid work were
more likely to want this information (v2 ¼
5.687, 1 df, P ¼ 0.017; v2 ¼ 27.000, 12 df, P ¼
0.008, respectively). Many women predicted the
information would make them anxious but
reported they wanted the information anyway.
Women with less education (v2 ¼ 15.533, 1 df,
P < 0.001) were more likely to predict infor-
mation about false results would make them
anxious.
Side-effects
One third of women said their doctor never
explained a test may have side-effects (see Table 5).
Women less than 50 (v2 ¼ 10.851, 1 df, P ¼ 0.001)
and women born in Australia (v2 ¼ 14.796, 3 df,
P ¼ 0.002) were more likely to report their
doctor at least sometimes explained a test might
have a side-effect. Almost all women wanted
information about side-effects the next time
they had a test, even though many reported
it would make them anxious. Women aged
30–39 were more likely to want this information
the next time they had a test (v2 ¼ 6.733,
1 df, P ¼ 0.009). Women with less education
Table 4 Reported decision-making
role and information preferences for








Timing of last mammogram
<2 years ago 27.0 80.3
2–5 years ago 40.0 16.5
6–10 years ago 17.1 2.7
>10 years ago 15.9 0.5
Reported decision-making role*
Woman decided 45.5 60.6
Decided together 49.4 25.7
Doctor decided 36.0 13.8
Information on benefits
Wanted more 23.8 18.1
As much as wanted 73.8 79.2
More than wanted 2.3 2.7
Information on side-effects
Wanted more 41.2 33.2
As much as wanted 57.6 65.9
More than wanted 1.2 0.9
*Significant difference between diagnostic and screening mammogram (P < 0.001).
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(v2 ¼ 9.493, 1 df, P ¼ 0.002) were more likely to
predict this information would make them
anxious.
Discussion
This survey is the first to interview a community
sample about their preferences for involvement
in test decisions and their information needs in
relation to tests. The sample is representative of
the general population of women aged 30–
69 years in NSW as derived from Australian
census data,27 given that we deliberately over
sampled older women, and achieved a high re-
sponse rate. Thus, the results are likely to be
applicable in other similar Western populations,
although the transferability of the findings to
other populations needs to be assessed.
The most striking finding of the study is that
the majority of women reported they would
prefer to participate equally in decision-making
with their doctor for decisions about both tests
and treatment or to take a more active role. This
finding was consistent across all age groups.
Overall, only a small proportion of women
(0.0–11.4%) reported they would want the doc-
tor to make the decision on their behalf. The
preference for shared decision-making is con-
sistent with previous research on treatment
preferences in community16 and non-patient
samples.3,11,14,15 However, this is the first study
to document similar preferences for shared deci-
sion-making in decisions about tests. Although
preferences were very similar, women’s reported
experiences were strikingly different for tests and
treatment. While the majority reported shared
decision-making for treatment, overall the most
common experience of test decision-making
(excluding pap smears) was the doctor deciding
alone. Thus, a discrepancy between preferences
and reported experience is apparent in the arena
of test decisions.
There were a number of differences in the
demographic factors associated with the pre-
ferred decision-making role for tests and treat-
ment. In particular, age was related to preferred
test and treatment decisional role and receiving
and wanting information about side-effects with
younger women being more likely to want active
involvement and more information. Education
was also related to preferred test and treatment
decisional role, satisfaction with information
about test benefits, reported treatment decisional
role, and predicted anxiety about information on
false results and side-effects. The relationship
between age and preferred treatment decision-
making role is consistent with previous research,
showing younger women are more likely to want
an active role in decision-making.8,28–30 In addi-
tion, the relationship between education and
preferred treatment decision-making role is also
consistent with previous research showing people
with more education prefer greater participation
in decision-making.29,31 However, it is unclear to
what extent these demographic relationships are
practically important, as previous research has
found that demographic factors account for not
more than 15% of the variation in decision-
making preference for treatment decisions.11,28
Therefore, it cannot be assumed that individuals
who belong to demographic groupings generally
Table 5 Desire for and anxiety related to information about










Want this information n ¼ 582 n ¼ 591
Definitely yes 65.1 77.5
Probably yes 25.9 17.8
Probably no 5.5 2.4
Definitely no 3.4 2.4
Information cause anxiety n ¼ 580 n ¼ 572
Definitely yes 16.4 10.1
Probably yes 30.2 33.0
Probably no 24.7 32.9
Definitely no 18.8 24.0
Want information despite anxiety* n ¼ 365 n ¼ 280
Yes 77.6 88.1
No 16.2 9.6
Don’t know 6.2 2.2
*Among those women who reported this information would definitely
or probably make them anxious.
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disinterested in active decision-making will
themselves be so disinterested. Doctors may need
to establish information and involvement pref-
erences with each patient, perhaps at each con-
sultation in order to clarify the patient’s current
preferences, as there is evidence that preferences
may vary over time.25
In this study, women with a usual doctor were
significantly more likely to report an active role
in test and treatment decision-making. This
finding suggests that a pre-existing doctor–
patient relationship may affect the extent to
which a patient participates in decision-making.
Further research is needed to determine if, and
to what extent a pre-existing doctor–patient
relationship influences the role a patient plays in
making test and treatment decisions.
Women reported they want to be well-
informed about the possibility of receiving a
false test result, and about any adverse effects of
tests. A large proportion of the women surveyed
reported not being regularly informed that a test
could have a false result or side-effects, and they
reported being more satisfied with the infor-
mation they received on the benefits of treat-
ments and tests than the information on adverse
effects. If women are not receiving balanced
information about tests, it is questionable whe-
ther they are making an informed decision to
undergo the test. It should be noted that this
study relied on reported information: whether
information is being provided but not heard
needs to be assessed.
In addition, many women recognized that
being more informed about tests may provoke
anxiety. These women nevertheless reported a
strong desire for such information, even if they
expect it will trigger anxiety. This finding sup-
ports guidelines released by The General Med-
ical Council in the United Kingdom about the
information that should be provided to people
about the consequences of undergoing screening
tests,17 including the probability of receiving a
false report, and any adverse effects of the test or
follow-up tests. Given that this study has inclu-
ded both screening and diagnostic tests, it seems
reasonable that this recommendation should
extend to people undergoing diagnostic tests.
The results also suggest that health-care pro-
viders, including family doctors, need to be
aware that many women want information
about test accuracy, that such information may
cause anxiety, but that this anxiety does not
prevent many women from wanting the infor-
mation. Thus, health-care providers should not
use concerns about anxiety to prevent them from
offering women the chance to receive this infor-
mation or providing it in caseswherewomenwant
it. Combined with the findings on preferred
decision-making role for tests, it appears that
most women want information about test accu-
racy but also want input by the doctor into the
decision about whether to undergo a test.
Before the findings of this study can be
effectively incorporated into clinical practice and
health-care professionals start providing this
information, it would be pertinent to assess what
type of information women want about test
benefits, side-effects and the possibility of a false
result; who they want to provide the information;
when they want to receive it; how they want it
presented; and what, if any, between-test differ-
ences exist. For example, dowomenwant detailed
statistical information about every possible side-
effect; do they want to know the more common
side effects or only the serious ones? Do they want
this information in a booklet or from a doctor?
These questions need to be answered as the pro-
vision of information about side-effects, benefits
and false results is necessary if women are to be
fully informed and able to participate in decisions
about whether to undergo medical tests.
Acknowledgements
This research was supported by a grant from the
National Health and Medical Research Council,
Australia.
References
1 Bachmann MO. Ought patients to follow profes-
sional advice? Health Expectations, 2001; 4: 141–143.
2 Coulter A. Paternalism or partnership? Patients have
grown up – and there’s no going back. British
Medical Journal, 1999; 319: 719–720.
 Blackwell Science Ltd 2002 Health Expectations, 5, pp.330–340
Medical tests: women’s preferences and experience, H M Davey et al. 339
3 Coulter A. Partnerships with patients: the pros and
cons of shared clinical decision making. Journal of
Health Services Research and Policy, 1997; 2: 112–
121.
4 Emmanuel EJ, Emmanuel LL. Four models of the
physician-patient relationship. Journal of the Ameri-
can Medical Association, 1992; 267: 2221–2226.
5 Entwistle V, Sheldon TA, Sowden A, Watt IS.
Evidence-informed patient choice. Practical issues of
involving patients in decisions about health care
technologies. International Journal of Technology
Assessment in Health Care, 1998; 14: 212–225.
6 National Health and Medical Research Council.
General Guidelines for Medical Practitioners on Pro-
viding Information to Patients. Canberra: Australian
Government Printing Service, 1994.
7 Bilodeau BA, Degner LF. Information needs, sources
of information, and decisional roles in women with
breast cancer. Oncology Nursing Forum, 1996; 23:
691–696.
8 Blanchard CG, Labrecque MS, Ruckdeschel JC,
Blanchard EB. Information and decision-making
preferences of hospitalized adult cancer patients.
Social Science and Medicine, 1998; 27: 1139–1145.
9 Davison BJ, Degner LF, Morgan TR. Information
and decision making preferences of men with pros-
trate cancer. Oncology Nursing Forum, 1995; 22:
1401–1408.
10 Degner L, Kristjanson L, Bowman D et al. Infor-
mation needs and decisional preferences in women
with breast cancer. Journal of the American Medical
Association, 1997; 277: 1485–1492.
11 Degner L, Sloan J. Decision making during serious
illness: what role do patients really want to play?
Journal of Clinical Epidemiology, 1992; 45: 941–950.
12 Hack TF, Degner LF, Dyck DG. Relationship
between preferences for decisional control and illness
information among women with breast cancer: a
quantitative and qualitative analysis. Social Science
and Medicine, 1994; 39: 279–289.
13 McKinstry B. Do patients wish to be involved in
decision making in the consultation? A cross sec-
tional survey with video vignettes. British Medical
Journal, 2000; 321: 867–871.
14 Rothenbacher D, Lutz MP, Porzsolt F. Treatment
decisions in palliative cancer care: patients
preferences for involvement and doctors knowledge
about it. European Journal of Cancer, 1997; 33: 1184–
1189.
15 Stiggelbout AM, Kiebert GM. A role for the sick:
patient preferences regarding information and parti-
cipation in clinical decision-making. Canadian Med-
ical Association Journal, 1997; 157: 383–389.
16 Vertinsky IB, Thompson WA, Uyeno D. Measuring
consumer desire for participation in clinical decision
making. Health Services Research, 1974; 9: 121–134.
17 General Medical Council. Seeking Patients Consent:
The Ethical Considerations. London: General Med-
ical Council, 1998.
18 Barratt A, Cockburn J, Furnival C, McBride A,
Mallon L. Perceived sensitivity of mammographic
screening: women’s views on test accuracy and
financial compensation for missed cancers. Journal
of Epidemiology and Community Health, 1999; 53:
716–720.
19 Barratt AL, Cockburn J, Redman S, Paul C, Perkins
J. Mammographic screening: results from the 1996
National Breast Health Survey. Medical Journal of
Australia, 1997; 167: 521–524.
20 Barratt A, Cockburn J, Smith D, Redman S.
Reliability and validity of women’s recall of mam-
mographic screening. Australian & New Zealand
Journal of Public Health, 2000; 24: 79–81.
21 Australian Institute of Health and Welfare (AIHW),
Australasian Association of Cancer Registries and
NHMRC National Breast Cancer Centre. Breast
Cancer in Australian Women 1982–1996. Canberra:
Australian Institute of Health and Welfare, 1999.
22 Australian Institute of Health and Welfare (AIHW).
BreastScreen Australia Achievement Report 1997 –
1998. Canberra: Australian Institute of Health and
Welfare, 2000.
23 Degner L, Sloan JA, Venkatesh, P. The control
preferences scale. Canadian Journal of Nursing
Research, 1997; 29: 21–43.
24 Landis JR, Koch GG. The measurement of observer
agreement for categorical data. Biometrics, 1977; 33:
159–174.
25 Butow PN, McLean M, Dunn SM, Tattersall MHN,
Boyer M. The dynamics of change: cancer patients
preferences for information, involvement and sup-
port. Annals of Oncology, 1997; 8: 857–863.
26 SPSS Inc. SPSS version 10.0.5 for Windows. Chicago,
IL: SPSS Inc., 1999.
27 Australian Bureau of Statistics. Data provided on
request.
28 Catalan J, Brener N, Andrews H et al. Whose health
is it? Views about decision-making and information-
seeking from people with HIV infection and their
professional careers. AIDS Care, 1994; 6: 349–356.
29 Strull WM, Lo B, Charles G. Do patients want to
participate in medical decision making? Journal of the
American Medical Association, 1984; 252: 2990–2994.
30 Cassileth BR, Zupkis RV, Sutton-Smith K, March V.
Information and participation preferences among
cancer patients. Annals of Internal Medicine, 1980;
92: 832–836.
31 Ende J, Kazis L, Ash A, Moskowitz MA. Measuring
patients desire for autonomy: decision making and
information-seeking preferences among medical
patients. Journal of General Internal Medicine, 1989;
4: 23–30.
 Blackwell Science Ltd 2002 Health Expectations, 5, pp.330–340
Medical tests: women’s preferences and experience, H M Davey et al.340
